①Murata Y,
Kotani T,
Supriatna Y, Kitamura Y, Imada S, Kawahara K, Nishio M,
Daniwijaya EW,
Sadakata H, Kusakari S, Mori M, Kanazawa Y, Saito Y, Okawa K,
Takeda-Morishita
M, Okazawa H, Ohnishi H, Azuma T, Suzuki A, Matozaki T., Protein
tyrosine
phosphatase SAP-1 protects against colitis through regulation of
CEACAM20 in
the intestinal epithelium. Proc Natl Acad
Sci U S A. 112(31) E4264-71, 2015
②Minami K,
Shinsato Y,
Yamamoto M, Takahashi H, Zhang S, Nishizawa Y, Tabata S, Ikeda R, Kawahara
K,
Tsujikawa K, Chijiiwa K, Yamada K, Akiyama S, Pérez-Torras S,
Pastor-Anglada M,
Furukawa T, Yasuo T., Ribonucleotide reductase is an effective target
to
overcome gemcitabine resistance in gemcitabine-resistant pancreatic
cancer cells
with dual resistant factors.
J Pharmacol Sci.
127(3):319-25, 2015
③Minami K,
Kamijo Y,
Nishizawa Y, Tabata S, Horikuchi F, Yamamoto M, Kawahara K,
Shinsato Y,
Tachiwada T, Chen ZS, Tsujikawa K, Nakagawa M, Seki N, Akiyama S, Arima
K,
Takeda Y, Furukawa T., Expression of ABCB6 Is Related to Resistance to
5-FU,
SN-38 and Vincristine.
Anticancer Res.
34(9):4767-73, 2014
④Maehama
T, Kawahara
K, Nishio M, Suzuki A, Hanada K., Nucleolar Stress Induces
Ubiquitination-Independent Proteasomal Degradation of PICT1., J. Biol.
Chem, 289(30):20802-20812, 2014
⑤Okamura
K, Takayama K,
Kawahara K, Harada T, Nishio M, Otsubo K, Ichijo K, Kohno
M, Iwama E,
Fujii A, Ota K, Koga T, Okamoto T, Suzuki A, Nakanishi Y ., PICT1
expression is
a good prognostic factor in non-small cell lung cancer., ONCOSCIENCE
1(5):375, 2014
⑥Shinsato
Y, Furukawa
T, Yunoue S, Yonezawa H, Minami K, Nishizawa Y, Ikeda R, Kawahara K,
Yamamoto M, Hirano H, Tokimura H, and Arita K., Reduction of MLH1 and
PMS2
confers temozolomide resistance and is associated with recurrence of
glioblastoma., Oncotarget,
4(12):2261-70, 2013
⑦Uchi R,
Kogo R, Kawahara
K, Sudo T, Yokobori T, Eguchi H, Sugimachi K, Maehama T, Mori M,
Suzuki A,
Komune S, Mimori K., PICT1 regulates TP53 via RPL11 and is involved in
gastric
cancer progression., Br J
Cancer.
109(8):2199-206, 2013
⑧Liao J,
Marumoto T,
Yamaguchi S, Okano S, Takeda N, Sakamoto C, Kawano H, Nii T, Miyamato
S, Nagai
Y, Okada M, Inoue H, Kawahara K, Suzuki A, Miura Y, Tani K.,
Inhibition
of PTEN Tumor Suppressor Promotes the Generation of Induced Pluripotent
Stem
Cells., Molecular
Therapy,
21(6):1242-1250,
2013
⑨河原康一., 核小体ストレス応答によるp53-MDM2経路の制御., 生化学, 85,
152-9, 2013年
⑩Miyoshi K
, Yanagi S ,
Kawahara K, Nishio M, Tsubouchi H, Imazu Y, Koshida R,
Matsumoto N,
Taguchi A, Yamashita S, Suzuki A, and Nakazato M., Epithelial Pten
Controls
Acute Lung Injury and Fibrosis by Regulating Alveolar Epithelial Cell
Integrity., Am J
Respir Crit Care Med,
187(3):262-75. 2013
⑪西尾美希, 河原康一, 佐々木雅人,
前濱朝彦, 佐々木雄彦,
三森功士, 森正樹,
鈴木聡., 核小体を起点としp53を制御する新規分子PICT1による細胞増殖制御機構., 実験医学, 31,
257-64, 2013年
⑫河原康一, 西尾美希,
佐々木雅人, 前濱朝彦,
佐々木雄彦, 古後龍之介,
三森功士,森
正樹, 鈴木
聡., PICT1による核小体ストレス経路を介したp53と腫瘍進展制御-腫瘍予後マーカーや今後の創薬応用に向けて-, 遺伝子医学MOOK,
22,260-5, 2012
⑬Suzuki A,
Kogo R, Kawahara
K, Sasaki M, Nishio M, Maehama T, Sasaki T, Mimori K, Mori M., A
new
PICTure of nucleolar stress., Cancer Sci. 103,
632-7, 2012
⑭Nishio M,
Hamada K*,
Kawahara K*, Sasaki M, Noguchi F, Chiba S,
Mizuno K, Suzuki
SO, Dong Y, Tokuda M, Morikawa T, Hikasa H, Eggenschwiler J, Yabuta N,
Nojima
H, Nakagawa K, Hata Y, Nishina H, Mimori K, Mori M, Sasaki T, Mak TW,
Nakano T,
Itami S, Suzuki A., Cancer susceptibility and embryonic lethality in
Mob1a/1b
double-mutant mice., J Clin
Invest,
122(12):4505-18,
2012 (*:These two authors are contributed equally to this
work as a
second author)
⑮Kogo R,
Shimamura T,
Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K,
Suzuki A,
Komune S, Miyano S, and Mori M., Long non-coding RNA HOTAIR regulates
Polycomb-dependent chromatin modification and is associated with poor
prognosis
in colorectal cancers. Cancer Res,
71(20):6320-6, 2011
⑯Sasaki M*,
Kawahara
K*, Nishio M, Mimori K, Kogo R, Hamada K , Itoh B,
Wangjia J,
Komatsu Y, Yang R.Y, Hikasa H, Horie Y, Yamashita T, Kamijo T, Zhang Y,
Prives
C, Nakano T, Mak W.T, Sasaki T, Maehama T, Mori M and Suzuki A.,
Regulation of
the MDM2-p53 Pathway and Tumor Growth by PICT1/GLTSCR2 via Nucleolar
RPL11., Nature
Medicine,
17(8):944-51, 2011 (*:These two authors
are contributed equally to this work as a first author)
⑰河原康一、佐々木雄彦、西尾美希、鈴木聡., がん抑制遺伝子PTEN異常による各種疾患~PTEN欠損マウスが教えてくれたもの~., 生化学, 80,
1017-25, 2008年
⑱Inoue-Narita
T, Hamada
K, Sasaki T, Hatakeyama S, Fujita S, Kawahara K, Sasaki M,
Kishimoto H,
Eguchi S, Kojima I, Beermann F, Kimura T, Osawa M, Itami S, Mak TW,
Nakano T,
Manabe M, Suzuki A., Pten deficiency in melanocytes results in
resistance to
hair graying and susceptibility to carcinogen-induced melanomagenesis.,
Cancer Res,
68(14):5760-8, 2008
⑲Kuroda S,
Nishio M,
Sasaki T, Horie Y, Kawahara K, Sasaki M, Natsui M, Matozaki T,
Tezuka H,
Ohteki T, Forster I, Mak TW, Nakano T, Suzuki A., Effective clearance
of
intracellular Leishmania major in vivo requires Pten in macrophages., Eur J
Immunol,38(5):1331-40,2008
⑳Kawahara K,
Hashimoto M, Bar-On
P, Ho GJ, Crews L, Mizuno H, Rockenstein E, Imam SZ, Masliah E.,
alpha-Synuclein aggregates interfere with Parkin solubility and
distribution:
role in the pathogenesis of Parkinson disease., J.
Biol. Chem,283(11):6979-87,2008
㉑河原康一、濱田浩一、佐々木雄彦、鈴木聡.,
PTEN/PI3K経路による血管制御., 医学のあゆみ, 27,
480-485, 2007年
㉒Yanagi S,
Kishimoto H, Kawahara
K, Sasaki T, Sasaki M, Nishio M, Yajima N, Hamada K, Horie Y, Kubo
H,
Whitsett JA, Mak TW, Nakano T, Nakazato M, Suzuki A., Pten controls
lung
morphogenesis, bronchioalveolar stem cells, and onset of lung
adenocarcinomas
in mice., J Clin
Invest,117(10):2929-40,2007
October, IF=
13.765
㉓Kishimoto
H, Ohteki T, Yajima N, Kawahara
K, Natsui M, Kawarasaki S, Hamada K, Horie Y, Kubo Y, Arase S,
Taniguchi M,
Vanhaesebroeck B, Mak TW, Nakano T, Koyasu S, Sasaki T, Suzuki A., The
Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells., Blood,109(8):3316-24,
2007
㉔Tsuruta
H, Kishimoto H, Sasaki T,
Horie Y, Natsui M, Shibata Y, Hamada K, Yajima N, Kawahara K,
Sasaki M,
Tsuchiya N, Enomoto K, Mak TW, Nakano T, Habuchi T, Suzuki A.,
Hyperplasia and
carcinomas in Pten-deficient mice and reduced PTEN protein in human
bladder
cancer patients., Cancer Res, 66(17),
8389-96, 2006
㉕Hashimoto
M, Kawahara K,
Bar-On P, Rockenstein E, Crews L, Masliah E. , The Role of
alpha-synuclein
assembly and metabolism in the pathogenesis of Lewy body disease., J Mol
Neurosci, 24,
343-52, 2004
㉖Kawahara K,
Morishita T,
Nakamura T, Hamada F, Toyoshima K, and Akiyama T., Downregulation of
beta-catenin by The Colorectal Tumor Suppressor APC Requires
Association with
Axin and beta-catenin., J. Biol.
Chem,275(12), 8369-8374., 2000
㉗Nakamura
T, Hamada F, Ishidate T,
Anai K, Kawahara K, Toyoshima K and Akiyama T., Axin, an
inhibitor of
the Wnt signaling pathway, interacts with beta-catenin, GSK-3beta and
APC and
reduces the beta-catenin level., Genes.Cells,3(6),
395-403,1998
㉘河原康一、植月太一、斎藤泉、吉川和明., ニューロン特異的核蛋白質necdinの機能解析., 神経化学 35(3),
374-375, 19
|